Podcasts | EASD

Dr. De Franco’s work has revolutionised the understanding and treatment of this rare form of diabetes, diagnosed in babies under six months old. From identifying 10 - 15 genetic mutations linked to neonatal diabetes to shedding light on beta cell biology, Elisa’s discoveries are transforming lives and advancing diabetes research. She also shares a glimpse of her Minkowski Lecture, offering exciting discoveries that highlight the power of genetics in medicine.

Adipose tissue isn't just "fat" - it's a remarkable endocrine organ with transformative impacts on health and diabetes. In this episode, discover groundbreaking insights from Dr. Alice Williamson of Queen Mary University, London, and Dr. Lori Goodyear of Harvard Medical School.

Learn about the genetic factors behind insulin resistance and the revolutionary role of exercise in remodelling adipose tissue. From genetic breakthroughs to potential therapies, this discussion unpacks the future of diabetes care. Find out why fat is more than just a roll around your middle - it’s a key player in metabolic health!

In this episode, Alice Rickford and Andrzej Kokoszka discuss the complex challenges of managing diabetes in disadvantaged communities and among individuals with mental health conditions.

Alice Rickford, a healthcare professional from London, highlights barriers like homelessness, access to care, and the stigma faced by people living with diabetes in vulnerable situations. Andrzej Kokoszka, from Poland, sheds light on the relationship between mental health and diabetes, focusing on depression, body image issues, and the role of self-management. The conversation offers practical advice for clinicians, emphasizing the need for a holistic, patient-centred approach to care, and how building trust and providing emotional support are key to improving patient outcomes.

In Episode 3 of our podcast, experts from Argentina, Mexico, Pakistan, and Sri Lanka share a comprehensive view of the diabetes epidemic in their countries. The conversation highlights the alarming rise in diabetes and pre-diabetes cases, touching on the challenges faced by their healthcare systems and the urgent need for government intervention.

Dr. Prasad Katulanda (Sri Lanka) discusses the exponential growth in diabetes rates, while Dr. Abdul Basit (Pakistan) talks about the push for government action and better healthcare funding. Dr. Javier Farias (Argentina) and Dr. Leonardo Mancillas (Mexico) also share the growing concern over obesity and the steps their countries are taking to address it through public policy, prevention programmes, and healthcare reform.

Episode 2 features Matthias Blüher and Anette Ziegler, two leading experts in diabetes research, as they share their insights into the future of diabetes care by 2030.

The conversation explores innovative developments in the prevention and treatment of both Type 1 and Type 2 diabetes, with a focus on early diagnosis, immune interventions, and the potential of incretin-based therapies. Dr. Blüher discusses the exciting possibilities of personalised medicine and new pharmacotherapies, while Dr. Ziegler emphasizes the importance of primary prevention and the latest research into viral triggers.

This episode delves into the evolving landscape of diabetes care and the potential to revolutionise treatment options in the next decade.

Our first episode features Dr. Roy Taylor, a leading diabetes researcher and recipient of the prestigious EASD Claude Bernard Prize, discussing groundbreaking insights into type 2 diabetes remission.

He shares his journey in proving that type 2 diabetes can, in many cases, be reversed through targeted weight loss to reduce fat in the liver and pancreas. Dr. Taylor recounts the challenges he faced in gaining acceptance for his theories and highlights the role of media and patient stories in spreading awareness.

His approach has influenced a shift in treatment options, including the development of a national programme in the NHS for diabetes remission.

You are here